Articles

Simmering trade wars have created a sort of stop-and-start economy — and the latest snapshot of retail sales in May underscores the threat to U.S. growth.

Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.

After Israel attacked Iran on June 13, U.S. Treasury yields rose while other countries’ bond yields declined.

Trump is testing how far he can push the Fed without breaking it. Why you should care about his choices.

A long-running index from Cars.com that ranks automobiles on factors such as U.S.-based assembly and domestic sourcing of parts has gone electric this year, with six electric vehicles making the top 10 for the first time.

Are budget cuts to Medicaid and Medicare really necessary? Here’s how they could be avoided.

The euro trails the U.S. dollar and gold for global central reserves, and European Central Bank President Christine Lagarde described how to change it.

Patrick Kelly, co-manager of a top-performing Alger fund, wants investors to wake up over AI before they miss a big opportunity.

Taking Social Security before your full retirement age may have profound consequences.

Investors haven’t been as pessimistic on the U.S. dollar in two decades, according to a closely tracked survey released Tuesday.

“My niece, as smart and brilliant as she is, is not very good with her money.”

Citi forecasts a return to $2500-2700 gold prices in the second half of 2026.